Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB
Document Type: Research Article
Affiliations: 1: Center for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, Soauth Africa 2: Treatment Action Group, New York, NY, USA 3: Médecins Sans Frontières (MSF), Khayelitsha, South Africa 4: Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, and Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa 5: Eswatini National TB Control Programme, Manzini, Eswatini 6: Global TB Program, Baylor College of Medicine, Houston, TX, USA 7: Hinduja Hospital & Research Centre, Mumbai, India 8: MSF, Cape Town, South Africa 9: Independent Consultant, Maputo, Mozambique 10: Republican Scientific and Practical Centre for Pulmonology and TB, Minsk, Belarus 11: Department of Infectious Diseases, Imperial College London, UK, and Desmond Tutu TB Centre, Department of Paediatrics and Child Health, University of Stellenbosch, Tygerberg, South Africa 12: National Department of Health, Mahikeng, North West Province, South Africa 13: Partners In Health (PIH), Boston, MA, USA 14: National Department of Health, Johannesburg, Gauteng Province, South Africa 15: PIH, Maseru, Lesotho 16: MSF, Eshowe, South Africa 17: National Tuberculosis and Leprosy Programme, Ministry of Health, Lusaka, Zambia 18: Health Systems Research Unit, South African Medical Research Council, Durban, South Africa 19: Interactive Research and Development, Karachi 20: Interactive Research and Development, Karachi, Pakistan, and Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK 21: Desmond Tutu TB Centre, Stellenbosch University, Cape Town, South Africa 22: MSF, Paris, France 23: Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
Publication date: November 1, 2020
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.
To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.
Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites